Evidence map›Paper›PMID 36839543›Full record

ReviewPathogens (Basel, Switzerland)2023

Exploring Possible Ways to Enhance the Potential and Use of Natural Products through Nanotechnology in the Battle against Biofilms of Foodborne Bacterial Pathogens.

Kannappan Arunachalam, Ganesh Prasath Krishnan, Sathya Sethuraman, Sybiya Vasantha Packiavathy Issac Abraham, Swetha Thirukannamangai Krishnan, Aakanksha Venkateswar, Jagadeesan Arunkumar, Chunlei Shi, Davoodbasha MubarakAli

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Kannappan ArunachalamMOST-USDA Joint Research Center for Food Safety, Department of Food Science and Technology, School of Agriculture and Biology, and State Key Lab of Microbial Metabolism, Shanghai Jiao Tong University, Shanghai 200240, China.ORCID 0000-0001-5958-8900
Ganesh Prasath KrishnanDepartment of Biotechnology, Sri Venkateswara College of Engineering, Sriperumbudur 602117, Tamil Nadu, India.
Sathya SethuramanDepartment of Biotechnology, Alagappa University, Karaikudi 630002, Tamil Nadu, India.
Sybiya Vasantha Packiavathy Issac AbrahamDepartment of Biotechnology, Karunya Institute of Technology and Sciences, Coimbatore 641114, Tamil Nadu, India.
Swetha Thirukannamangai KrishnanDepartment of Pediatrics, Ann and Robert H Lurie Children's Hospital of Chicago, Northwestern University, Chicago, IL 60611, USA.
Aakanksha VenkateswarDepartment of Biotechnology, Sri Venkateswara College of Engineering, Sriperumbudur 602117, Tamil Nadu, India.
Jagadeesan ArunkumarDepartment Clinical and Translational Sciences, Joan C. Edward School of Medicine, Marshall University, Huntington, WV 25755, USA.ORCID 0000-0001-7665-595X
Chunlei ShiMOST-USDA Joint Research Center for Food Safety, Department of Food Science and Technology, School of Agriculture and Biology, and State Key Lab of Microbial Metabolism, Shanghai Jiao Tong University, Shanghai 200240, China.ORCID 0000-0002-5847-7122
Davoodbasha MubarakAliSchool of Life Sciences, B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai 620048, Tamil Nadu, India.ORCID 0000-0001-8133-8676
Shanghai Jiao Tong University · CNAlagappa University · INB.S. Abdur Rahman Crescent Institute of Science & Technology · INKarunya University · INMarshall University · USNorthwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biofilms enable pathogenic bacteria to survive in unfavorable environments. As biofilm-forming pathogens can cause rapid food spoilage and recurrent infections in humans, especially their presence in the food industry is problematic. Using chemical disinfectants in the food industry to prevent biofilm formation raises serious health concerns. Further, the ability of biofilm-forming bacterial pathogens to tolerate disinfection procedures questions the traditional treatment methods. Thus, there is a dire need for alternative treatment options targeting bacterial pathogens, especially biofilms. As clean-label products without carcinogenic and hazardous potential, natural compounds with growth and biofilm-inhibiting and biofilm-eradicating potentials have gained popularity as natural preservatives in the food industry. However, the use of these natural preservatives in the food industry is restricted by their poor availability, stability during food processing and storage. Also there is a lack of standardization, and unattractive organoleptic qualities. Nanotechnology is one way to get around these limitations and as well as the use of underutilized bioactives. The use of nanotechnology has several advantages including traversing the biofilm matrix, targeted drug delivery, controlled release, and enhanced bioavailability, bioactivity, and stability. The nanoparticles used in fabricating or encapsulating natural products are considered as an appealing antibiofilm strategy since the nanoparticles enhance the activity of the natural products against biofilms of foodborne bacterial pathogens. Hence, this literature review is intended to provide a comprehensive analysis of the current methods in nanotechnology used for natural products delivery (biofabrication, encapsulation, and nanoemulsion) and also discuss the different promising strategies employed in the recent and past to enhance the inhibition and eradication of foodborne bacterial biofilms.

Indexed as

antibiofilmbiofabricationfoodborne pathogensnanocarriernatural preservatives

Identifiers

PMID36839543
PMCPMC9967150
OpenAlexW4319598892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.